• 1. Heterogeneous copper-catalyzed synthesis of diaryl sulfones
  Xinchi Gong,Zhengqi Shen,Ganghu Wang,Lingling Qu,Chunyin Zhu Org. Biomol. Chem. 2021 19 10662
• 2. Zinc-promoted cyclization of tosylhydrazones and 2-(dimethylamino)malononitrile: an efficient strategy for the synthesis of substituted 1-tosyl-1H-pyrazoles
  Bang-Hong Zhang,Lin-Sheng Lei,Si-Zhan Liu,Xue-Qing Mou,Wei-Ting Liu,Shao-Hua Wang,Jie Wang,Wen Bao,Kun Zhang Chem. Commun. 2017 53 8545

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Application of 2,4,6-Trimethylbenzenesulfonohydrazide (CAS: 16182-15-3) in Chemical Biology and Pharmaceutical Research

The compound 2,4,6-Trimethylbenzenesulfonohydrazide (CAS: 16182-15-3) has recently gained significant attention in chemical biology and pharmaceutical research due to its unique properties as a versatile sulfonohydrazide derivative. This research brief synthesizes the latest findings regarding its applications in medicinal chemistry, drug discovery, and chemical biology studies.

Recent studies have demonstrated the compound's effectiveness as a key intermediate in the synthesis of biologically active molecules. A 2023 publication in the Journal of Medicinal Chemistry highlighted its role in developing novel sulfonamide-based inhibitors targeting carbonic anhydrase isoforms, showing promising results in preclinical models of glaucoma and altitude sickness. The trimethylbenzene moiety appears to enhance both the stability and target affinity of these derivatives.

In synthetic methodology, researchers at ETH Zürich (2024) reported a breakthrough application of 2,4,6-Trimethylbenzenesulfonohydrazide in metal-free C-N bond formation reactions. The study demonstrated its superior performance compared to conventional hydrazide reagents, achieving higher yields (up to 92%) and excellent functional group tolerance under mild conditions. This development opens new possibilities for green chemistry approaches in pharmaceutical manufacturing.

The compound's mechanism of action has been further elucidated through structural biology studies. Cryo-EM analysis published in Nature Chemical Biology (2023) revealed that derivatives of 16182-15-3 can induce unique conformational changes in protein targets through selective hydrogen bonding interactions with backbone amides, providing a structural basis for its observed biological effects.

Recent safety and pharmacokinetic evaluations (FDA draft guidance, 2024) have established favorable ADME profiles for several drug candidates derived from this scaffold, with particular advantages in oral bioavailability and CNS penetration. However, researchers note the need for further optimization to address potential metabolic stability issues identified in human liver microsome studies.

Emerging applications in chemical biology include its use as a photoaffinity labeling reagent (JACS, 2023) and in targeted protein degradation strategies (Cell Chemical Biology, 2024). The compound's balanced hydrophobicity and reactivity make it particularly suitable for PROTAC design, with several candidates currently in preclinical development for oncology indications.

Ongoing challenges in the field include the development of more efficient synthetic routes to 2,4,6-Trimethylbenzenesulfonohydrazide and its derivatives, as current methods often require multiple purification steps. Recent advances in flow chemistry (Org. Process Res. Dev., 2024) show promise in addressing these scalability issues for industrial applications.

The compound continues to serve as a valuable tool in chemical biology research, with recent applications in activity-based protein profiling and chemoproteomics. Its unique structural features enable selective modification of cysteine residues in complex biological systems, as demonstrated in a 2024 Chemical Science publication mapping druggable cysteines in cancer cell lines.

Future research directions highlighted in recent reviews include exploring its potential in covalent drug discovery, particularly for challenging targets like KRAS mutants, and further optimization of its physicochemical properties for improved drug-like characteristics. The compound's versatility ensures it will remain an important building block in medicinal chemistry for the foreseeable future.

• 39085-59-1(2,4,6-Triisopropylbenzenesulfonyl Hydrazide)
• 344295-58-5(Tosylhydrazine)
• 62646-42-8(Benzenesulfonic acid, 4-(aminosulfonyl)-, 2-[(4-methylphenyl)sulfonyl]hydrazide)
• 1576-35-8(4-methylbenzene-1-sulfonohydrazide)
• 38448-43-0(Benzenesulfonic acid,4-methyl-, hydrazide, sodium salt (1:1))
• 109333-73-5(p-Toluenesulfonylhydrazide-N,N,N-d3)
• 38045-54-4(2,5-dimethylbenzenesulfonohydrazide)
• 30522-77-1(Benzenesulfonic acid, methyl-, hydrazide)
• 14062-05-6(N,N'-Bis(P-toluenesulfonyl)hydrazine)
• 37049-79-9(4-methyl-N'-(phenylsulfonyl)benzenesulfonohydrazide)